CORONA Remedies Ltd. benchmarking: Performance to industry peers

Financial

	CORONA Remedies	Abbott India	Alkem Laboratories
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	2.0 %	0.02 %	6.4 %
Financials
5 yr Average ROE	22.27 %	30.11 %	17.38 %
5yr average Equity Multiplier	1.72	1.43	1.39
5yr Average Asset Turnover Ratio	1.19	1.14	0.86
5yr Avg Net Profit Margin	11.05 %	18.53 %	14.54 %
Price to Book	15.48	11.39	4.69
P/E	62.44	35.04	28.16
5yr Avg Cash Conversion Cycle	-134.66 Days	-46.68 Days	-61.46 Days
Inventory Days	36.93 Days	45.22 Days	56.11 Days
Days Receivable	34.91 Days	19.34 Days	44.62 Days
Days Payable	183.34 Days	109.21 Days	122.42 Days
5yr Average Interest Coverage Ratio	22.85	97.37	24.48
5yr Avg ROCE	27.26 %	38.77 %	22.76 %
5yr Avg Operating Profit Margin	17.68 %	23.42 %	18.44 %
5 yr average Debt to Equity	0.15	0.0	0.18
5yr CAGR Net Profit	16.86 %	95.4 %	6.44 %
5yr Average Return on Assets	13.03 %	21.03 %	12.47 %
Shareholdings
Promoter Holding	69.0 %	74.99 %	51.2 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-5.96 %
Change in Mutual Fund Holding (3 Yrs)	3.91 %	0.8 %	5.38 %

	CORONA Remedies	Abbott India	Alkem Laboratories
Location Wise Break-Up	Location Wise Break-Up India 95.9 Outside India 4.1 Rest of the World 0 USA 0	Location Wise Break-Up India 98.81 Outside India 0 USA 0 Rest of the World 1.19	Location Wise Break-Up India 65.5 Outside India 0 USA 34.5 Rest of the World 0
Acute vs Chronic	Acute vs Chronic Acute 71.9 Chronic and subchronic 28.1 Sub-chronic 0 Chronic 0	Acute vs Chronic Sub-chronic 27.0 Acute 27.0 Chronic 46.0 Chronic and subchronic 0	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Women’s Healthcare 27.5 Cardio-diabeto 25.4 Pain Management 11.4 Urology 2.9 Others 32.8	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 98.49 Others 1.51	-	-